J Gen Virol Try Microbiology Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 70 (1989), 3079-3084; DOI 10.1099/0022-1317-70-11-3079
© 1989 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laux, G.
Right arrow Articles by Farrell, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laux, G.
Right arrow Articles by Farrell, P. J.
Agricola
Right arrow Articles by Laux, G.
Right arrow Articles by Farrell, P. J.

The Terminal Protein Gene 2 of Epstein-Barr Virus Is Transcribed from a Bidirectional Latent Promoter Region

Gerhard Laux, Androulla Economou and Paul J. Farrell

Ludwig Institute for Cancer Research, St Mary's Branch, St Mary's Hospital Medical School, Norfolk Place, London W2 1PG, U.K.

The intact terminal protein genes (TP1 and TP2) of Epstein-Barr virus (EBV) are created upon infection by circularization of the linear viral genome at its terminal repeats. The structure of the 1.7 kb TP2 latent mRNA has been determined by cDNA analysis and Northern blotting, revealing its close relation to TP1 mRNA. The 1.7 kb transcript is expressed from a different promoter and has a different 5' exon from TP1 but is also spliced across the terminal repeats. The last eight exons are common to the TP1 and TP2 RNAs. The TP2 promoter is 3.3 kb downstream of the TP1 promoter and is part of a bidirectional latent EBV promoter region transcribing the TP2 and the latent membrane protein RNAs in opposite directions.

Keywords: EBV, transcription, latent cycle

Received 25 February 1989; accepted 10 July 1989.


This article has been cited by other articles:


Home page
J. Virol.Home page
M. Rovedo and R. Longnecker
Epstein-Barr Virus Latent Membrane Protein 2B (LMP2B) Modulates LMP2A Activity
J. Virol., January 1, 2007; 81(1): 84 - 94.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Jimenez-Ramirez, A. J. Brooks, L. P. Forshell, K. Yakimchuk, B. Zhao, T. Z. Fulgham, and C. E. Sample
Epstein-Barr Virus EBNA-3C Is Targeted to and Regulates Expression from the Bidirectional LMP-1/2B Promoter
J. Virol., November 15, 2006; 80(22): 11200 - 11208.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
A. I. Bell, K. Groves, G. L. Kelly, D. Croom-Carter, E. Hui, A. T. C. Chan, and A. B. Rickinson
Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays.
J. Gen. Virol., October 1, 2006; 87(Pt 10): 2885 - 2890.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. M. Brinkmann and T. F. Schulz
Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae.
J. Gen. Virol., May 1, 2006; 87(Pt 5): 1047 - 1074.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Peng, S. C. Moses, J. Tan, E. Kremmer, and P. D. Ling
The Epstein-Barr Virus EBNA-LP Protein Preferentially Coactivates EBNA2-Mediated Stimulation of Latent Membrane Proteins Expressed from the Viral Divergent Promoter
J. Virol., April 1, 2005; 79(7): 4492 - 4505.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
E. Schaadt, B. Baier, J. Mautner, G. W. Bornkamm, and B. Adler
Epstein-Barr virus latent membrane protein 2A mimics B-cell receptor-dependent virus reactivation
J. Gen. Virol., March 1, 2005; 86(3): 551 - 559.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. Salamon, M. Takacs, D. Ujvari, J. Uhlig, H. Wolf, J. Minarovits, and H. H. Niller
Protein-DNA Binding and CpG Methylation at Nucleotide Resolution of Latency-Associated Promoters Qp, Cp, and LMP1p of Epstein-Barr Virus
J. Virol., March 15, 2001; 75(6): 2584 - 2596.
[Abstract] [Full Text]


Home page
J. Virol.Home page
P. Rivailler, C. Quink, and F. Wang
Strong Selective Pressure for Evolution of an Epstein-Barr Virus LMP2B Homologue in the Rhesus Lymphocryptovirus
J. Virol., October 1, 1999; 73(10): 8867 - 8872.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
P. Speck, K. A. Kline, P. Cheresh, and R. Longnecker
Epstein-Barr virus lacking latent membrane protein 2 immortalizes B cells with efficiency indistinguishable from that of wild-type virus
J. Gen. Virol., August 1, 1999; 80(8): 2193 - 2203.
[Abstract] [Full Text]


Home page
J. Clin. Microbiol.Home page
A. A. T. P. Brink, M. B. H. J. Vervoort, J. M. Middeldorp, C. J. L. M. Meijer, and A. J. C. van den Brule
Nucleic Acid Sequence-Based Amplification, a New Method for Analysis of Spliced and Unspliced Epstein-Barr Virus Latent Transcripts, and Its Comparison with Reverse Transcriptase PCR
J. Clin. Microbiol., November 1, 1998; 36(11): 3164 - 3169.
[Abstract] [Full Text]


Home page
BloodHome page
G. Niedobitek, E. Kremmer, H. Herbst, L. Whitehead, C.W. Dawson, E. Niedobitek, C. von Ostau, N. Rooney, F.A. Grasser, and L.S. Young
Immunohistochemical Detection of the Epstein-Barr Virus-Encoded Latent Membrane Protein 2A in Hodgkin's Disease and Infectious Mononucleosis
Blood, August 15, 1997; 90(4): 1664 - 1672.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1989 by the Society for General Microbiology.